1Lyophilized drug client
Take the case of a client with a lyophilized orphan drug that was looking for differentiation as generic competition approached. We optimized their formulation for shorter lyophilization cycle time improving COGS. But we also increased the speed of reconstitution and packaged the new formulation in our patented Lyotip container closure to add a unique point of differentiation.
Patient market research with current customers showed that they rated the Lyotip system higher than any existing options for reconstitution and ease of use.
A respected biosimilar firm was interested in unique formulations of existing products, particularly lyophilized IV drugs.
Integrity Bio was able to take their lyophilized drug and successfully formulate liquid versions over 200mg/ml.
A pharmaceutical company was seeking a simple way to deliver multiple doses of lyophilized products in a manner as easy as a prefilled syringe.
We were able to adapt our Lyotip system to support multiple administrations from one syringe.